INSIGHTS ON DRUG DEVELOPMENT

• KORSCH Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging

  Simulate high-speed tablet production early in development with minimal material. Gain accurate scale-up, faster material characterization, and flexible formulation options—all with one compaction simulator.

• EMA Support For SMEs Through Scientific Advice And Early Dialogue

  Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and de‑risk innovative programs through early dialogue.

• The Innovation Of Testing Conjugated ADC Molecules

  Explore how evolving ADCs are reshaping testing strategies, from potency and binding to purity, as well as what is required to evaluate both traditional cytotoxic payloads and emerging modalities.

• Direct API Capsule Filling: A Faster Path To Market

  Direct API capsule filling eliminates complex formulation steps, leveraging volumetric drum dosing and 100% net weight verification to accelerate drug development timeline efficiency.

• Delivering Critical Therapies With Speed And Safety

  6/26/2026

  Faster approvals depend on treating regulation as part of development, not the finish line. See how early quality planning and strong agency communication can move therapies toward patients sooner.

• The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly

  3/3/2025

  In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.

• AI Enabled Pharmaceutical Cocrystal Screening

  9/3/2026

  Cocrystal candidate screening is resource-intensive and prone to gaps. This paper examines how AI-based modeling, trained on more than 20,000 data points, can sharpen candidate prioritization without sacrificing scientific rigor.

• Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety

  9/16/2025

  Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.

• Overview Of Hot Melt Extrusion And Its Pharmaceutical Applications

  8/31/2026

  More than 40% of NCEs face aqueous solubility challenges. Here, we examine how hot melt extrusion addresses solubility, modified release, abuse deterrence, and scale-up across pharmaceutical development.